← Leaderboards
Daniel Kreisel
St. Louis Va Medical Center
$15,012,786
Attributed
$30,489,986
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$46,917,629 · 10
VA$0 · 1
By mechanism
P01$20,515,627 · 5
U01$15,471,597 · 1
R01$10,325,605 · 3
K08$604,800 · 1
I01$0 · 1
Top collaborators
- Andrew Eric Gelman14 shared
- Ramsey Hachem5 shared
- Joren C Madsen5 shared
- Alexander Sasha Krupnick4 shared
- Kory J. Lavine4 shared
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingPathway InteractionsImmuneTransplantationTransplant RecipientsCellsResponseImmune ResponseLungLung TransplantationLung AllograftOrganTissuesGraft RejectionPlayLaboratoriesMolecularPreventInflammatoryT-LymphocyteReperfusion InjurySignal TransductionCuesInflammation
Grant awards (63)
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab$3,310,755
U01 · FY2025 · AI
Pathways Regulating Lung Transplant Tolerance$1,500,000
P01 · FY2025 · AI · contact PI
The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection$694,901
R01 · FY2025 · HL · contact PI
Local and peripheral mechanisms of T cell-mediated immune regulation after lung transplantation$312,032
P01 · FY2025 · AI · contact PI
Leukocyte trafficking in thoracic grafts$0
I01 · FY2025 · VA · contact PI
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab$3,256,574
U01 · FY2024 · AI
Pathways Regulating Lung Transplant Tolerance.$1,490,366
P01 · FY2024 · AI · contact PI
The Role of Lymphoid Neogenesis in the Maintenance of Lung Transplant Tolerance$373,015
P01 · FY2024 · AI · contact PI
Leukocyte trafficking in thoracic grafts$0
I01 · FY2024 · VA · contact PI
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab$3,130,730
U01 · FY2023 · AI
Pathways Regulating Lung Transplant Tolerance.$1,512,016
P01 · FY2023 · AI · contact PI
The Role of Donor Innate Immune Responses in Regulating Alloimmunity after Heart Transplantation$626,852
R01 · FY2023 · HL · contact PI
The Role of Lymphoid Neogenesis in the Maintenance of Lung Transplant Tolerance$375,913
P01 · FY2023 · AI · contact PI
Leukocyte trafficking in thoracic grafts$0
I01 · FY2023 · VA · contact PI
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab$3,063,266
U01 · FY2022 · AI
Pathways Regulating Lung Transplant Tolerance.$1,528,208
P01 · FY2022 · AI · contact PI
The Role of Donor Innate Immune Responses in Regulating Alloimmunity after Heart Transplantation$636,632
R01 · FY2022 · HL · contact PI
The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection$530,808
R01 · FY2022 · HL · contact PI
The Role of Lymphoid Neogenesis in the Maintenance of Lung Transplant Tolerance$379,290
P01 · FY2022 · AI · contact PI
Leukocyte trafficking in thoracic grafts$0
I01 · FY2022 · VA · contact PI
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab$2,710,272
U01 · FY2021 · AI
Pathways Regulating Lung Transplant Tolerance.$1,561,764
P01 · FY2021 · AI · contact PI
The Role of Donor Innate Immune Responses in Regulating Alloimmunity after Heart Transplantation$643,875
R01 · FY2021 · HL · contact PI
The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection$530,809
R01 · FY2021 · HL · contact PI
The Role of Lymphoid Neogenesis in the Maintenance of Lung Transplant Tolerance$386,852
P01 · FY2021 · AI · contact PI
Pathways Regulating Lung Transplant Tolerance.$1,600,284
P01 · FY2020 · AI · contact PI
The Role of Donor Innate Immune Responses in Regulating Alloimmunity after Heart Transplantation$668,251
R01 · FY2020 · HL · contact PI
The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection$530,808
R01 · FY2020 · HL · contact PI
The Role of Lymphoid Neogenesis in the Maintenance of Lung Transplant Tolerance$393,646
P01 · FY2020 · AI · contact PI
Leukocyte trafficking in thoracic grafts$0
I01 · FY2020 · VA · contact PI
Pathways Regulating Lung Transplant Tolerance$1,433,206
P01 · FY2019 · AI · contact PI
The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection$529,123
R01 · FY2019 · HL · contact PI
The Role of Lymphoid Neogenesis in Lung Transplant Tolerance$368,792
P01 · FY2019 · AI · contact PI
Leukocyte trafficking in thoracic grafts$0
I01 · FY2019 · VA · contact PI
Pathways Regulating Lung Transplant Tolerance$1,442,522
P01 · FY2018 · AI · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$392,686
R01 · FY2018 · HL · contact PI
The Role of Lymphoid Neogenesis in Lung Transplant Tolerance$371,190
P01 · FY2018 · AI · contact PI
Leukocyte trafficking in thoracic grafts$0
I01 · FY2018 · VA · contact PI
Pathways Regulating Lung Transplant Tolerance$1,447,614
P01 · FY2017 · AI · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$392,686
R01 · FY2017 · HL · contact PI
The Role of Lymphoid Neogenesis in Lung Transplant Tolerance$372,499
P01 · FY2017 · AI · contact PI
Leukocyte trafficking in thoracic grafts$0
I01 · FY2017 · VA · contact PI
Pathways Regulating Lung Transplant Tolerance$1,451,526
P01 · FY2016 · AI · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$392,686
R01 · FY2016 · HL · contact PI
The Role of Lymphoid Neogenesis in Lung Transplant Tolerance$373,505
P01 · FY2016 · AI · contact PI
Leukocyte trafficking in thoracic grafts$0
I01 · FY2016 · VA · contact PI
Pathways Regulating Lung Transplant Tolerance$1,460,137
P01 · FY2015 · AI · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$392,686
R01 · FY2015 · HL · contact PI
The Role of Lymphoid Neogenesis in Lung Transplant Tolerance$381,250
P01 · FY2015 · AI · contact PI
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE$374,300
R01 · FY2015 · HL · contact PI
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE$372,400
R01 · FY2014 · HL · contact PI
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE$361,760
R01 · FY2013 · HL · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$358,142
R01 · FY2013 · HL · contact PI
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCE$380,000
R01 · FY2012 · HL · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$376,200
R01 · FY2012 · HL · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$380,000
R01 · FY2011 · HL · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$380,000
R01 · FY2010 · HL · contact PI
Vascular Endothelium Directs the Development of Regulatory T Cells$120,960
K08 · FY2010 · HL · contact PI
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTION$380,000
R01 · FY2009 · HL · contact PI
Vascular Endothelium Directs the Development of Regulatory T Cells$120,960
K08 · FY2009 · HL · contact PI
Vascular Endothelium Directs the Development of Regulatory T Cells$120,960
K08 · FY2008 · HL · contact PI
Vascular Endothelium Directs the Development of Regulatory T Cells$120,960
K08 · FY2007 · HL · contact PI
Vascular Endothelium Directs the Development of Regulatory T Cells$120,960
K08 · FY2006 · HL · contact PI